Briefcases -- Drugs -- ACTEMRA (tocilizumab) by Genentech USA, Inc. (Roche Group)

ACTEMRA (tocilizumab) by Genentech USA, Inc. (Roche Group)

Case Files
News
Committees
Request a Document
Request
Search Within Briefcase

Folders

  1. Single Event Case Filings
  2. Media References
  3. FDA Regulatory Materials

Quick Access

  1. ACTEMRA (tocilizumab) STAT Report (March 28, 2013)
  2. ACTEMRA (tocilizumab) Letter to Healthcare Providers (October 2013)
  3. ACTEMRA (tocilizumab) FDA Meeting Summary (June 26, 2008)
  4. ACTERMA (tocilizumab) Rheumatology News_"Tocilizumab raises cholesterol, but not cardiovascular events" (published December 7, 2016)
  5. ACTEMRA (tocilizumab) FDA Label (March 2017)
  6. ACTERMA (tocilizumab) Australian TAG Public Assessment Report (January 2015)
  7. ACTEMRA (tocilizumab) Fordham IP Institute "Current Developments in U.S. Patent Law" by Dimitrios T. Drivas (April 24, 2014)
  8. ACTEMRA (tocilizumab) FDA Summary Review (October 21, 2013)